SNOMED CT Drug Model Use Cases

Introduction

The SNOMED CT Pharmaceutical / Biologic Product hierarchy provides a structured model for representing medicinal products at multiple levels of abstraction. This hierarchy includes concepts such as Medicinal Product (MP), Medicinal Product Form (MPF), and Clinical Drug (CD), which progressively add detail about ingredients, dose form, and strength.

For example:

• A Medicinal Product (MP) represents a medicinal product defined only by its active ingredient(s), without specifying strength or dose form.

• A Clinical Drug (CD) represents a medicinal product defined by ingredient, strength, and manufactured dose form, making it suitable for use in clinical workflows.

The International Release focuses on representing medicinal products in a way that is globally consistent, while national extensions may add concepts representing actual authorized products and packaging available in specific jurisdictions, including branded medicines and product packages.

Together, the International Drug Model and National Drug Extensions support a wide range of healthcare use cases including prescribing, dispensing, logistics, reimbursement, pharmacovigilance, and clinical decision support.

Administrative use cases support operational and financial aspects of healthcare systems such as procurement, logistics, and reporting.

Healthcare organizations and national procurement agencies often purchase medicines through competitive tendering processes. In these processes, the purchasing authority defines the medication required using a generic specification, allowing suppliers to compete with their own authorized products.

The SNOMED CT drug model supports this process by separating generic drug definitions from real products available on the market. Procurement specifications can reference Clinical Drug (CD) concepts, while suppliers offer their products using Real Clinical Drug (RCD) and Real packaged Clinical Drug (RPCD) concepts defined in national extensions.

This approach ensures vendor-neutral procurement while maintaining precise definitions of the medicines being purchased.

Hospital pharmacies and distribution systems manage inventories of medications across warehouses, pharmacies, and clinical units. Stock management systems track package quantities, expiration dates, and product movement.

The SNOMED CT drug model supports these workflows by representing product packages using concepts such as Clinical Drug Package (CDP) and Real Clinical Drug Package (RPCD).

This allows inventory systems to track real packages while maintaining a link to the underlying clinical drug concept, and make this information available during the prescription process when necessary.

Health insurance systems and national payers define reimbursement policies for medications based on ingredients, formulations, or specific products.

The SNOMED CT drug model enables reimbursement rules to be defined at different levels of abstraction. For example, coverage policies may apply to all products containing a given ingredient or may apply only to specific strengths or formulations.

Healthcare organizations and public health authorities routinely analyze medication usage data to monitor prescribing patterns, drug costs, and treatment trends, and to support business intelligence activities such as forecasting demand, planning procurement, and optimizing medication supply.

The hierarchical structure of the SNOMED CT drug model enables aggregation of medication data at different levels of granularity. Data recorded at the clinical drug level can be automatically aggregated at higher levels, such as ingredient or drug class.

Clinical use cases focus on the use of medications in patient care workflows.

Electronic prescribing systems allow clinicians to select medications and send prescriptions electronically to pharmacies. These systems must represent medications with sufficient detail to ensure accurate dispensing.

SNOMED CT Clinical Drug (CD) concepts provide the appropriate level of detail for prescribing because they specify ingredient, strength, and dose form. In some cases, clinicians may prescribe a specific brand or package using Real Clinical Drug (RCD) or Real Packaged Clinical Drug (RPCD) concepts.

When a pharmacy receives a prescription, the pharmacist selects a product that fulfills the prescription. In many healthcare systems, pharmacists are allowed to substitute equivalent generic medicines.

The SNOMED CT drug model supports this workflow by linking Clinical Drug concepts with Real Clinical Drug concepts, enabling pharmacy systems to match prescriptions with available products.

In hospitals and other care settings, nurses administer medications to patients according to physician orders. Medication administration systems must record the exact product administered and verify that it matches the prescribed medication. Clinical decision support systems can support the administration step by checking contraindications, potential drug interactions, and dose appropriateness before the medication is given.

Closed-loop medication administration systems often use barcode scanning to identify the medication product before administration.

Pharmacovigilance systems collect reports of adverse reactions associated with medications. These systems must accurately identify the suspected drug to detect safety signals. If adverse reaction reports are generated directly from medication administration data recorded in the clinical record, the exact product administered can be captured without information loss, ensuring that the same product is reported to pharmacovigilance systems.

The SNOMED CT drug model allows adverse reactions to be recorded at different levels of specificity depending on available information.

Clinical decision support systems analyze medication orders and patient information to provide alerts and guidance to clinicians.

Typical decision support functions include drug–drug interaction checking, allergy alerts, and dose range validation.

The SNOMED CT drug model also supports knowledge management, research, and secondary uses of medication data.

Healthcare organizations and knowledge provider companies maintain drug knowledge databases containing information about drug interactions, contraindications, dosing guidance, and therapeutic indications.

The SNOMED CT drug model allows knowledge to be linked to standardized drug concepts, enabling consistent application and simple integration across clinical systems.

Electronic health records maintain medication lists representing drugs that a patient is currently taking or has taken previously. These lists support medication reconciliation and continuity of care.

Medication records may represent drugs at different levels depending on available information.

Researchers and public health authorities analyze medication data to study treatment outcomes, safety, and prescribing trends. Current medication use is also commonly used as a criterion for patient selection and eligibility in clinical studies.

The hierarchical structure of SNOMED CT drug concepts allows researchers to aggregate medication data at different levels.